A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/70 (2006.01) A61K 31/00 (2006.01) A61K 31/335 (2006.01) A61K 31/40 (2006.01) A61K 31/475 (2006.01) A61K 31/505 (2006.01) A61K 31/565 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2411172
The present invention provides the combined use of acryloyl distamycin derivatives, in particular .alpha.-bromo- and .alpha.-chloro-acryloyl distamycin derivatives of formula (I), as set forth in the specification, and an antineoplastic topoisomerase I or II inhibitor, in the treatment of tumors. Also provided is the use of the said combinations in the treatment or prevention of metastasis or in the treatment of tumors by inhibition of angiogenesis.
Cette invention a trait à l'utilisation combinée, aux fins du traitement de tumeurs, de dérivés de distamycine acryloyle, notamment de dérivés de alpha -bromo et de alpha -chloro distamycine acryloyle correspondant à la formule (I), comme définie dans le descriptif, et d'un inhibiteur de la topoisomérase I ou II à action antinéoplasique. L'invention concerne également l'utilisation de ces combinaisons pour le traitement ou la prévention des métastases ou encore pour le traitement de tumeurs par inhibition de l'angiogenèse.
Beria Italo
Cozzi Paolo
Geroni Maria Cristina Rosa
Nerviano Medical Sciences S.r.l.
Pharmacia & Italia S.p.a.
Smart & Biggar
LandOfFree
Combined therapy against tumors comprising substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined therapy against tumors comprising substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined therapy against tumors comprising substituted... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1341623